Zura Bio Limited Stock Analysis & AI Score
Zura Bio Limited (ZURA) has an ST Score of 53.8 (B-), driven by its Financial Strength (A+) and held back by its Growth (D). Analysts rate it Buy with a $20.00 price target (+380.8% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Zura Bio Limited (ZURA) has an ST Score of 53.8 (B-), driven by its Financial Strength (A+) and held back by its Growth (D). Analysts rate it Buy with a $20.00 price target (+380.8% upside).
- Strongest
- Financial StrengthA+
- Weakest
- GrowthD
All factor grades
- Financial StrengthA+
- ForecastA
- ValuationB-
- MomentumB-
- ProfitabilityC+
- GrowthD
- Piotroski2/9
Contact
ZURA stock: frequently asked questions
What is ZURA's ST Score?
Zura Bio Limited (ZURA) has an ST Score of 53.8 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ZURA a buy, hold, or sell?
Analysts rate ZURA a Buy, with a price target of $20.00 (+380.8% vs the current price). Our ST Score grades it B- (53.8/100). The ST Score is a data-driven signal, not a recommendation.
What are ZURA's factor grades?
Valuation B-, Profitability C+, Financial Strength A+, Momentum B-, Growth D, Forecast A.
What is ZURA's valuation grade?
Zura Bio Limited (ZURA) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ZURA's growth grade?
Zura Bio Limited (ZURA) earns a growth grade of D, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ZURA's profitability grade?
Zura Bio Limited (ZURA) earns a profitability grade of C+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ZURA's financial strength grade?
Zura Bio Limited (ZURA) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ZURA?
The average analyst price target for Zura Bio Limited (ZURA) is $20.00 from 8 analysts, which is +380.8% versus the recent price of $4.16.
What is ZURA's Piotroski score?
Zura Bio Limited (ZURA) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.